Nicholas J. Short, MD

Nicholas Short, MD is an assistant professor in the Department of Leukemia at The University of Texas MD Anderson Cancer Center in Houston, Texas.

Articles by Nicholas J. Short, MD

MRD in Ph+ ALL: How Do You Measure It and What Does It Mean?

ByNicholas J. Short, MD

September 6th 2023

Although it is well-established that MRD negativity plays an important prognostic role in Ph-positive ALL, the optimal method to assess MRD in this disease and how to use this information therapeutically are still being established.

Latest Updated Articles

MRD in Ph+ ALL: How Do You Measure It and What Does It Mean?
Published: September 6th 2023 | Updated:

Nicholas J. Short, MD

Articles by Nicholas J. Short, MD

MRD in Ph+ ALL: How Do You Measure It and What Does It Mean?

Latest Updated Articles

Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways

FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL

Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC

Safusidenib Shows Robust, Ongoing Responses in Grade 2 IDH1-Mutant Glioma

Sac-TMT Demonstrates Antitumor Activity, Safety in Urothelial Carcinoma

LP-184 Demonstrates Favorable Efficacy and Safety in Advanced Solid Tumors